'Nuclear factor kappa B' in peripheral leukocytes is increased in patients with ischemia-reperfusion injury;'Nuclear factor kappa B' in perifere leukocyten is verhoogd bij patiënten met ischemie-reperfusieschade

Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde

Volumn 32, Issue 4, 2007, Pages 274-276

  Smets, E M L ^a   Umans, V A W M ^a   Hautvast, R W M ^a   Oomes, J ^a   Chevallier, M ^a   Van Stijn, M F M ^a   Houdijk, A P J ^a  

^a Medical Centre Alkmaar   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649264670     PISSN: 15708306     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006; 52: 601-23.
2. Macdonald J, Galley HF, Webster NR. Oxidative stress and gene expression in sepsis. Br J Anaest 2003; 90: 221-32.
3. Kefaloyianni E, Gaitanaki C, Beis I. ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts. Cell Sign 2006; 18: 2238-51.
4. Zhou LZ, Johnson AP, Rando TA. NF kappa B and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. Free Radic Biol Med 2001; 31: 1405-16.
5. Bhakuni P, Chandra M, Misra MK. Oxidative stress parameters in erythrocytes of post-reperfused patients with myo cardial infarction. J Enzyme Inhib Med Chem 2005; 20: 377-81. (Pubitemid 41269285)
6. Berg K, Jynge P, Bjerve K, Skarra S, Basu S, Wiseth R. Oxidative stress and inflammatory response during and following coronary interventions for acute myocardial infarction. Free Radic Res 2005; 39: 629-36.
7. Berg K, Wiseth R, Bjerve K, Brurok H, Gunnes S, Skarra S et al. Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release. Free Radic Res 2004; 358: 517-25. (Pubitemid 38618374)
8. Fleige S, Walf V, Huch S, Prgomet C, Sehm J, Pfaffl MW. Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR. Biotechn Letters 2006; 28: 1601-13.
9. Bir LS, Demir S, Rota S, Kaseoglu M. Increased serum malondialdehyde levels in chronic stage of ischemic stroke. Tohoku J Exp Med 2006; 208: 33-9.
10. Hozawa A, Ebihara S, Ohmori K, Kuriyama S, Ugajin T, Koizumi Y et al. Increased plasma 8-isoprostane levels in hypertensive subjects: the Tsurugaya Project. Hypertens Res 2004; 27: 557-61.
11. McGrath LT, McGleenon BM, Brennan S, McColl D, McILroy S, Passmore AP. Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM 2001; 94: 485-90. (Pubitemid 32894467)
12. Templar J, Kon SP, Milligan TP, Newman DJ, Raftery MJ. Increased plasma malondialdehyde levels in glomerular disease as determined by a fully validated HPLC method. Nephrol Dial Transplant 1999; 14: 946-51.
13. Gasparetto C, Malinverno A, Culacciati D, Gritti D, Prosperini PG, Specchia G et al. Antioxidant vitamins reduce oxidative stress and ventricular remodeling in patients with acute myocardial infarction. Int J Immunopathol Pharmacol 2005; 18: 487-496.
14. Aoi W, Naito Y, Takanami Y, Kawai Y, Sakuma K, Ichikawa H et al. Oxidative stress and delayed-onset muscle damage after exercise. Free Radic Biol Med 2004; 37: 480-7. (Pubitemid 38901080)
15. Lefer DJ, Granger DN. Oxidative stress and cardiac disease. Am J Med 2000; 109: 315-23.
16. Nikolic-Heitzler V, Rabuzin F, Tatzber F, Vrkic N, Bulj N, Borovic S et al. Persistent oxidative stress after myocardial infarction treated by percutaneous coronary intervention. Tohoku J Exp Med 2006; 210: 247-55.